| CRISPR Medicine | This is an overview of all our articles
Some of the best links we picked up around the internet
Professor Stephanie Cherqui of University of California San Diego’s School of Medicine recently received a prestigious grant from the Californian...
In this clinical update, we look at four ongoing clinical trials involving a gene-edited therapeutic candidate for the treatment of solid cancers.
To mark the start of 2023, we look back on some of the key advances in gene-editing clinical trials from 2022.
Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease.
